Announcing the fourth Annual National Hemophilia Foundation Annual Meeting Pre-Conference Symposium, Enhancing the Value of Managed Care and Specialty Pharmacy within the Hemophilia Comprehensive Care Model

NEW YORK--()--The National Hemophilia Foundation (NHF) and Impact Education, LLC (IMPACT) are pleased to announce the fourth annual pre-conference symposium specifically designed for specialty pharmacists, home health pharmacists, health plan pharmacists, managed Medicaid pharmacists, medical directors, and other healthcare professionals with an interest in the management of patients with hemophilia. This free, CME/CPE-certified activity is scheduled to take place on July 21, 2016 from 1:45 PM – 5:00 PM EDT at the Gaylord Palms Resort & Convention Center in Orlando, Florida, in conjunction with NHF’s 68th Annual Meeting, “A Brighter Future Together.”

Hemophilia is an expensive chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes require a collaborative and coordinated patient experience. The collaborative team can include an insurer, Hemophilia Treatment Center (HTC), and specialty pharmacy. Specialty pharmacy services can support patient adherence to treatment and assist physicians, plans, and employers in meeting clinical and/or financial goals. This symposium features a multidisciplinary expert panel, including a Specialty Pharmacist Expert, leading Hematologist, Hemophilia Treatment Center Nurse Coordinator, and a Managed Care Pharmacy Director. The program will provide an advanced clinical update and emphasize the need for well-coordinated treatment management, best practices to integrate hemophilia care with payer policies, and the value of having collaboration among all stakeholders.

Register today at http://www.impactedu.net/specialtypharmacy16; space is limited. The symposium is jointly provided by NHF, IMPACT, and the Postgraduate Institute for Medicine, and is supported by independent educational grants from Baxalta US Inc., Grifols, and Novo Nordisk, Inc.

About the National Hemophilia Foundation

The National Hemophilia Foundation (NHF) is dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research. Established in 1948, NHF is based in New York City with 51 chapters throughout the United States. NHF’s programs, initiatives and events are made possible through the generosity of individuals, corporations and foundations as well as through a cooperative agreement with the Centers for Disease Control and Prevention (CDC). For more information, visit the National Hemophilia Foundation Web site and follow us on Facebook and Twitter.

About Impact Education, LLC

IMPACT is an independent medical education and communications company dedicated to providing high quality educational programs. IMPACT’s mission is to develop education that improves patient outcomes in combination with increased health care efficiency and cost-effectiveness. The majority of activities developed by IMPACT are focused on the needs of the managed care and payer audiences. IMPACT has received the Alliance for CME Award for Outstanding Collaboration, which recognizes organizations that best demonstrate innovation or uniqueness in achieving effective CME/CE collaboration. For more information, visit www.impactedu.net and follow us on Facebook and Twitter.

Contacts

Impact Education, LLC
Steven Casebeer, MBA
215-619-8812, ext. 102
Steve.Casebeer@Impactedu.net

Release Summary

Announcing the 4th Annual National Hemophilia Foundation Annual Meeting Symposium, Enhancing the Value of Managed Care and Specialty Pharmacy within the Hemophilia Comprehensive Care Model

Contacts

Impact Education, LLC
Steven Casebeer, MBA
215-619-8812, ext. 102
Steve.Casebeer@Impactedu.net